ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $695,000 | -33.9% | 35,874 | -32.2% | 0.01% | -30.8% |
Q2 2022 | $1,051,000 | +259.9% | 52,905 | +321.7% | 0.01% | +333.3% |
Q4 2021 | $292,000 | +27.0% | 12,547 | +92.0% | 0.00% | 0.0% |
Q2 2021 | $230,000 | -44.3% | 6,534 | -47.2% | 0.00% | -62.5% |
Q3 2020 | $413,000 | – | 12,370 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 491,244 | $9,510,000 | 5.10% |
Decheng Capital Management III (Cayman), LLC | 623,342 | $12,068,000 | 4.38% |
TANG CAPITAL MANAGEMENT LLC | 1,099,516 | $21,287,000 | 2.61% |
Privium Fund Management B.V. | 300,252 | $5,624,000 | 2.04% |
Birchview Capital, LP | 117,000 | $2,265,000 | 1.60% |
Perceptive Advisors | 2,360,139 | $45,692,000 | 1.33% |
Chicago Capital, LLC | 1,119,774 | $21,679,000 | 1.25% |
Endurant Capital Management LP | 172,621 | $3,342,000 | 1.09% |
Deep Track Capital, LP | 1,110,624 | $21,502,000 | 0.98% |
SPHERA FUNDS MANAGEMENT LTD. | 359,000 | $6,950,000 | 0.96% |